1 |
Bydureon |
- |
- |
- |
- |
006 2件: 6 , 17 💬 |
2 |
Bydureon 2 mg powder and solvent for prolonged-release suspension |
- |
- |
- |
- |
006 1件: 6 💬 |
3 |
Exenatide |
Exenatide |
1件: D04121 D04121 💬 |
GLP1R 1件: GLP1R 💬 |
Insulin secretion 3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
006 4件: 6 , 17, 193, 233 💬 |
4 |
Exenatide 10 micrograms |
Exenatide |
1件: D04121 D04121 💬 |
GLP1R 1件: GLP1R 💬 |
Insulin secretion 3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
006 1件: 6 💬 |
5 |
Exenatide 5 micrograms |
Exenatide |
1件: D04121 D04121 💬 |
GLP1R 1件: GLP1R 💬 |
Insulin secretion 3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
006 1件: 6 💬 |
6 |
Exenatide extended release 2mg (bydureon) |
Exenatide |
1件: D04121 D04121 💬 |
GLP1R 1件: GLP1R 💬 |
Insulin secretion 3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
006 1件: 6 💬 |
7 |
Exenatide pen injector [bydureon] |
Exenatide |
1件: D04121 D04121 💬 |
GLP1R 1件: GLP1R 💬 |
Insulin secretion 3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
017 1件: 17 💬 |